Insulin-like Growth Factor-1 and Calcium Ion Levels are Negatively Associated with Serum β-Cross Laps in Multi-transfused β-thalassemia Major Patients
Abstract
BACKGROUND: Thalassemia patients with repeated transfusions (multi-transfusion) are often at risk of experiencing early osteoporosis. Several studies have demonstrated that osteoporosis in these individuals was associated with altered bone remodeling, characterized by decreased insulin-like growth factor-1 (IGF-1) and serum calcium ions, as well as increased serum β-Cross Laps (β-CTx) levels. Despite the prevalence of this condition, there is limited literature on the relationship between IGF-1 levels and calcium ions with β-CTx. Therefore, this study was conducted to examine the relationship between IGF-1 and calcium ions levels with serum β-CTx in multi-transfused β-thalassemia major patients.
METHODS: A cross sectional study involved 29 thalassemia patients with multiple transfusions, aged 2-18 years, that were selected from the electronic medical records. Calcium ion levels were examined using ion selective electrode method. Subsequently, IGF-1 and serum β-CTx levels were examined by enzyme-linked immunosorbent assay (ELISA), and the data were analyzed using the Pearson correlation test.
RESULTS: The results showed that the mean serum IGF-1 levels, calcium ion, and β-CTx were 20.11±20.763 ng/mL, 1.26±0.07 mmol/L, and 9330.40±1696.76 ng/mL, respectively. Statistical analysis showed a significant relationship between the levels of IGF-1 (r=-0.573; p=0.001) and calcium ion (r=-0.373; p=0.046) with serum β-CTx. A moderate negative relationship was found between IGF-1 levels and β-CTx, while calcium ion levels and β-CTx showed a weak negative relationship.
CONCLUSION: A moderate negative correlation between IGF-1 and serum β-CTx, and a weak negative correlation between calcium ion and serum β-CTx suggest that IGF-1 and calcium ions may serve as potential indicators of bone turnover and osteoporosis risk in multi-transfused β-thalassemia major patients, underscoring their potential role in routine clinical evaluations.
KEYWORDS: miR-200a expression, NO level, early-onset preeclampsia, late-onset preeclampsia
Full Text:
PDFReferences
Kementrian Kesehatan Republik Indonesia. Pedoman Nasional Pelayanan Kedokteran Tata Laksana Thalasemia. Jakarta: Kementrian Kesehatan Republik Indonesia; 2018, article.
Hoffman R , Benz E , Silberstein L, Heslop H , Weitz J, anastasi J, et al. Hematology Basic Principles and Practice Vol. 53. Seventh Ed. Philadelphia: Elsevier; 2018, article.
Kementrian Kesehatan Republik Indonesia. Keputusan Menteri Kesehatan Nomor HK.01.07/MENKES/1/2018 tentang Pedoman Nasional Pelayanan Kedokteran Tata Laksana Thalasemia. Jakarta: Kementrian Kesehatan Republik Indonesia; 2018, article.
Hoffbrand AV MP. Hoffbrand's Essential Haematology. Seventh Ed. Hoboken: Wiley Blackwell; 2016, article.
Patterson S, Singleton A, Branscomb J, Nsonwu V, Spratling R. Transfusion complications in thalassemia: Patient knowledge and perspectives. Front Med. 2022; 9: 772886, CrossRef.
Hendarto A, Sari TT, Rahmartani LD, Widyasari A, Iskandar SD. Glucose and lipid profiles in adolescents with thalassemia major and its association with iron overload in specific organs. Indones Biomed J. 2019; 11(2): 188-93, CrossRef.
Yutarti CS, Susilowati IT. Hubungan kadar feritin serum dengan tes fungsi hati pada pasien thalasemia mayor. Jurnal Kesehatan. 2023; 14(1): 42-8, CrossRef.
Sadiq IZ, Abubakar FS, Usman HS, Abdullahi AD, Ibrahim B, Kastayal BS, et al. Thalassemia: Pathophysiology, diagnosis, and advances in treatment. Thalass Rep. 2024; 14(4): 81-102, CrossRef.
Rowe A AJ. The Thalassemias and related disorders. Bayl Univ Med Cent. 2017; 20(1): 27-31, CrossRef.
Sohail, Ijaz F, Malik A, Kamran R, Javed S, Aftab RK. Assessment of insulin like growth factor 1 and bone density in normal and β-thalassemia major children. Pak J Physiol. 2019; 15(2): 52-5, article.
Candrarukmi D, Moelyo AG, Riza M. Glycated albumin as marker for early hyperglycemia detection in adolescent with β thalassemia major. Indones Biomedical J. 2021; 13(3): 281-8, CrossRef.
Zulauf N, Marzi I, Oremek GM. Prognostic value of bone marker beta-crosslaps in patients with breast carcinoma. Integr Cancer Sci Therap. 2014; 1(2): 12-6, CrossRef.
Yu U, Chen L, Wang X, Zhang X, Li Y, Wen F, et al. Evaluation of the vitamin D and biomedical statuses of young children with β-thalassemia major at a single center in southern China. BMC Pediatr. 2019; 19(1): 4-11, CrossRef.
Sahrir N. Physical activity, bone remodelling and bone metabolism markers bone remodelling. J Exerc Sport Orthop. 2018; 5(2): 1-4, CrossRef.
Greenblatt MB, Tsai JN, Wein MN. Bone turnover markers in the diagnosis and monitoring of metabolic bone sisease. Clin Chem. 2017; 63(2): 464-74, CrossRef.
Zhang J, Hu Y, Cai W. Bone metabolism factors in predicting the risk of osteoporosis fracture in the elderly. BMC Musculoskelet Disord. 2024; 25(1): 442, CrossRef.
Surjawan Y, Tan HL, Setiabudy RD, Rositawati W. Early screening of hemoglobinopathy in Indonesia using erythrocyte indices. Indones Biomed J. 2017; 9(2): 99-105, CrossRef.
Yüksel B, Özbek MN, Mungan NÖ, Darendeliler F, Budan B, Bideci A, et al. Serum IGF-1 and IGFBP-3 levels in healthy children between 0 and 6 years of age. J Clin Res Pediatr Endocrinol. 2011; 3(2): 84-8, CrossRef.
Riza M, Mulatsih S, Triasih R. Factors associated with insulin-like growth factor-1 in children with thalassemia major. Paediatr Indones. 2019; 59(2): 72-8, CrossRef.
Kim S, Yoo JW, Lee JW, Jung MH, Cho B, Suh BK, et al. Association of insulin-like growth factor-1 with bone mineral density in survivors of childhood acute leukemia. Cancers. 2024; 16(7): 1296, CrossRef.
Piga A. Impact of bone disease and pain in thalassemia. Hematology. 2017; 2017(1): 272-7, CrossRef.
Nabiel N, Nugroho HW, Moelyo AG. Vitamin D deficiency is associated with hypocalcemia in preterm infants. Mol Cell Biomed Sci. 2024; 8(2): 90-5, CrossRef.
Çelik T, Sangün Ö, Ünal Ş, Balcı A, Motor S. Assessment of biochemical bone markers of osteoporosis in children with thalassemia major. Ital J Pediatr. 2022; 48(1): 105, CrossRef.
Taher AT, Saliba AN. Iron overload in thalassemia: Different organs at different rates. Hematology Am Soc Hematol Educ Program. 2017; 2017(1): 265-71, CrossRef.
Ketherin K, Sandra F. Osteoclastogenesis in periodontitis: Signaling pathway, synthetic and natural inhibitors. Mol Cell Biomed Sci. 2018; 2(1): 11-8, CrossRef.
Peng C, Yang Q, Kong X, Sun Z, Wang L, Xiao L. Association of lymphocyte subsets and cytokines with bone metabolism: A retrospective, cross-sectional study. BMC Musculoskelet Disord. 2024; 25(1): 43, CrossRef.
Zhang W, Zhao W, Li W, Geng Q, Zhao R, Yang Y, et al. The imbalance of cytokines and lower levels of Tregs in elderly male primary osteoporosis. Front Endocrinol. 2022; 13: 779264, CrossRef.
Schini M, Vilaca T, Gossiel F, Salam S, Eastell R. Bone turnover markers: Basic biology to clinical applications. Endocr Rev. 2023; 44(3): 417-73, CrossRef.
Boraldi F, Lofaro FD, Quaglino D. Apoptosis in the extraosseous calcification process. Cells. 2021; 10(1): 131, CrossRef.
Gielecińska A, Kciuk M, Kontek R. The impact of calcium overload on cellular processes: Exploring calcicoptosis and its therapeutic potential in cancer. Int J Mol Sci 2024; 25(24): 13727, CrossRef.
Proudfoot D. Calcium signaling and tissue calcification. Cold Spring Harb Perspect Biol. 2019; 11(10): a035303, CrossRef.
Budaya TN, Daryanto B, Seputra KP, Fabrianta DM, Ekaputra AA, Dewi RARK, et.al. SARM Rad140 increases osteoblasts, muscle fiber size, myonuclei, and reduces osteoclasts in orchidectomized wistar rats. Mol Cell Biomed Sci. 2025; 9(1): 30-8, CrossRef.
DOI: https://doi.org/10.18585/inabj.v17i4.3706
Copyright (c) 2025 The Prodia Education and Research Institute
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Indexed by:
The Prodia Education and Research Institute
